KRT88P and acquired polycythemia vera: In this analysis of predictive factors for PV after 78 weeks of ETV treatment in a well-characterized cohort of CHB patients, we found that HBV DNA level ≥8 log10 IU/mL, Anti-HBc level<3 log10 IU/mL, and HBeAg seropositivity are independently predictive of failure to achieve CVR.